38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Some
1	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Paracetamol 80 mg rectal suppository	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Paracetamol 80 mg rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Aspirin 120 mg rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Some
Aspirin 120 mg rectal suppository	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely pentobarbital sodium 200 milligram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pentobarbital sodium 200 milligram/1 each conventional release rectal suppository (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Dimenhydrinate 50 mg chewable tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Dimenhydrinate 50 mg chewable tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Memantine hydrochloride 7 mg prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Memantine hydrochloride 7 mg prolonged-release oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely aspirin 200 milligram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely aspirin 200 milligram/1 each conventional release rectal suppository (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Clonidine hydrochloride 100 microgram/mL prolonged-release oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Some
Clonidine hydrochloride 100 microgram/mL prolonged-release oral suspension	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Fenofibric acid 135 mg gastro-resistant oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Fenofibric acid 135 mg gastro-resistant oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Linaclotide 290 microgram oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Linaclotide 290 microgram oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Glyceryl trinitrate 5 mg buccal tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Glyceryl trinitrate 5 mg buccal tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal film (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal film (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely aspirin 650 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely aspirin 650 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Loratadine 5 mg chewable tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Loratadine 5 mg chewable tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Acetic acid 9.2 mg/g vaginal gel	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Acetic acid 9.2 mg/g vaginal gel	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely ibuprofen 100 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ibuprofen 100 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Paracetamol 300 mg rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Some
Paracetamol 300 mg rectal suppository	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely naphazoline hydrochloride 300 microgram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely naphazoline hydrochloride 300 microgram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only droxidopa in oral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ketorolac trometamol 4.5 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely ketorolac trometamol 4.5 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Fluoxetine (as fluoxetine hydrochloride) 90 mg gastro-resistant oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Fluoxetine (as fluoxetine hydrochloride) 90 mg gastro-resistant oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ketorolac trometamol 4 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ketorolac trometamol 4 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely ascorbic acid 250 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely ascorbic acid 250 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Besifloxacin 6 mg/mL eye suspension	Count of base of active ingredient	False	1	Inferred relationship	Some
Besifloxacin 6 mg/mL eye suspension	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely bupropion hydrobromide 174 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely bupropion hydrobromide 174 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug)	Has presentation strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Paracetamol 325 mg rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Some
Paracetamol 325 mg rectal suppository	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely estropipate 1.5 milligram/1 milliliter conventional release vaginal cream (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely estropipate 1.5 milligram/1 milliliter conventional release vaginal cream (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely fentanyl 800 microgram/1 each conventional release buccal tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely fentanyl 800 microgram/1 each conventional release buccal tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Memantine hydrochloride 14 mg prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Memantine hydrochloride 14 mg prolonged-release oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Atropine sulfate 5 mg/g eye ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Atropine sulfate 5 mg/g eye ointment	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely topiramate 25 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely topiramate 25 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Topiramate 15 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Topiramate 15 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Mirtazapine 45 mg orodispersible tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Mirtazapine 45 mg orodispersible tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely pramipexole dihydrochloride 375 microgram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pramipexole dihydrochloride 375 microgram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Zolmitriptan 2.5 mg orodispersible tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Zolmitriptan 2.5 mg orodispersible tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some

Start Previous Page 174 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core